Show document

A+ | A- | | SLO | ENG

Title: Rak sečnega mehurja Authors: ID Velepič, Marija (Member of editorial board) ID Koblar, Olga (Member of editorial board) ID Bostič-Pavlovič, Jožica (Member of editorial board) Files: PDF - Presentation file, download (13,34 MB) MD5: 55440E29CCB3947E583D5959C5ADBC2C   Language: Slovenian Typology: 2.02 - Professional Monograph Organization: OI - Institute of Oncology Keywords: sečni mehur, rak (medicina), zdravljenje, bolniki, nega, posvetovanja, zborniki Publication status: Published Publication version: Version of Record Place of publishing: Ljubljana Place of performance: Ljubljana Publisher: Onkološki inštitut Year of publishing: 1992 Year of performance: 1992 Number of pages: [29] str. PID: 20.500.12556/DiRROS-10512  UDC: 616.62:616-006.6(082) COBISS.SI-ID: 29367808  Publication date in DiRROS: 13.01.2020 Views: 2823 Downloads: 798 Metadata:    Cite this work Plain text BibTeX EndNote XML EndNote/Refer RIS ABNT ACM Ref AMA APA Chicago 17th Author-Date Harvard IEEE ISO 690 MLA Vancouver : Rak sečnega mehurja, 1992. [online], Professional Monograph. Ljubljana : Onkološki inštitut. [Accessed 18 April 2025]. Retrieved from: https://dirros.openscience.si/IzpisGradiva.php?lang=eng&id=10512 Copy citation

Share: Similar works from our repository: Non-small cell lung cancer in countries of Central and Southeastern Europe NSCLC molecular testing in Central and Eastern European countries Trans-esophageal endobronchial ultrasound-guided needle aspiration (EUS-B-NA) Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer Similar works from other repositories: Vpliv izražanja receptorja za inzulinu podoben rastni dejavnik 1 (IGF1R) na preživetje pri razsejanem nedrobnoceličnem raku pljuč Širitev Evropske unije: ali navdušenje hlapi? Ne-srečno razmerje Usefulness of immunohistochemically determined epidermal growth factor receptor mutations in lung cancer Gene expression levels of the prolyl hydroxylase domain proteins PHD1 and PHD2 but not PHD3 are decreased in primary tumours and correlate with poor prognosis of patients with surgically resected non-small-cell lung cancer Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Back